Califano Named New Director of Moores Cancer Center at UC San Diego Health
Joseph A. Califano III, MD, has been named director of Moores Cancer Center at UC San Diego Health.
Skaggs School of Pharmacy and Pharmaceutical Sciences News
Featured Articles
Featured Stories
The Latest
Eight UC San Diego Researchers Among ‘1,000 Best Female Scientists in the World’
Eight researchers from UC San Diego are listed in the first-ever ranking of the “1,000 Best Female Scientists in the World” by research.com, an analytics platform that advocates for improved research quality and also ranks universities, scholarly journals and academic conferences.
Popular Pharmaceutical Target in Cells May Prove Even More Useful
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
UC San Diego Physician-Scientist Elected to National Academy of Medicine
Victor Nizet, MD, Distinguished Professor of Pediatrics at University of California San Diego School of Medicine and Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences, has been elected to the National Academy of Medicine.
UC San Diego Researchers Named Recipients of NIH New Innovator Awards
Two early career researchers at the University of California San Diego have been named recipients of the 2022 National Institutes of Health (NIH) Director’s New Innovator Award from the NIH Common Fund’s High-Risk, High-Reward Research program.
Survival Is a Mixed Matter for Deadliest of Pancreatic Cancers
UC San Diego researchers discover that quality and mix of protein in a type of pancreatic cancer is the determinant of whether the prognosis is poor or very poor.
Trending Stories
In the Media
UCSD tool can spot more than 4,000 drugs, a boon to patient care
San Diego Union-Tribune, December 9
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
